Helse Bergen HF

Oncology and Haematological Malignancies

Clinical research includes acute myeloid leukemia, high-risk myelodysplastic syndrome, breast cancer, pancreatic cancer, and recurrent grade IV glioma. The funded studies also address treatment response, resistance, and survival in aggressive cancer settings.

  • Acute myeloid leukemia
  • Breast cancer
  • Pancreatic cancer
  • Recurrent grade IV glioma

Research activity spans both solid tumours and blood cancers, with interest in personalised treatment strategies and disease control in difficult-to-treat malignancies.

Neurology and Neuroinflammatory Disease

Trials focus on multiple sclerosis, myalgic encephalomyelitis/chronic fatigue syndrome, and cluster headache, alongside studies in idiopathic sudden sensorineural hearing loss and long COVID. The portfolio also includes work on neuroregenerative and immune-related approaches in chronic neurological illness.

  • Multiple sclerosis
  • Myalgic encephalomyelitis/chronic fatigue syndrome
  • Chronic cluster headache
  • Idiopathic sudden sensorineural hearing loss

These studies reflect a strong interest in disabling neurological disorders, symptom burden, and functional recovery.

Gastroenterology, Endocrinology, and Ophthalmology

Research activity covers Crohn’s disease, primary adrenal insufficiency, mild autonomous cortisol secretion, and thyroid eye disease. Trials also examine metabolic and hormonal outcomes relevant to endocrine disorders.

  • Crohn’s disease
  • Primary adrenal insufficiency
  • Mild autonomous cortisol secretion
  • Thyroid eye disease

The sponsor supports clinical work across inflammatory bowel disease, adrenal disorders, cortisol excess, and orbital autoimmune disease.

Addiction Medicine and Psychiatric Metabolic Care

Studies include treatment for amphetamine dependence, benzodiazepine dependence, and comorbid dependence during opioid agonist therapy. Additional work addresses metabolic control in people using antipsychotic medication and weight-related outcomes in schizophrenia spectrum disorders.

  • Amphetamine dependence
  • Benzodiazepine dependence
  • Opioid agonist therapy
  • Schizophrenia spectrum disorders

This area combines substance use treatment with psychiatric and metabolic care in complex patient populations.

Infectious Disease, Immune Response, and Supportive Care

Clinical studies include virus diseases, influenza vaccine immunogenicity, and antiviral treatment related to acute COVID and long COVID. The portfolio also includes hypothermia research and hyperbaric oxygen therapy in acute hearing loss, reflecting interest in supportive interventions.

  • Virus diseases
  • Influenza vaccine immunogenicity
  • Long COVID
  • Hypothermia

These studies connect immune-focused research with acute care and symptom-directed interventions across several clinical settings.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of H5N8 Influenza Vaccine Response in Adults Previously Vaccinated with H5N1 Vaccine Compared to Those Never Vaccinated Against H5 Influenza

    Not recruiting

    3 1 1 1
    Norway
  • Study on Reducing Body Temperature in Healthy Volunteers Using Pethidine and Buspirone to Prevent Shivering

    Not recruiting

    2 1 1
    Norway
  • Study on Personalized Treatment for High-Risk Breast Cancer Using Palbociclib, Olaparib, and Pertuzumab in Patients with Advanced Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Norway
  • Study on Sonoporation-Enhanced Treatment with Gemcitabine, Nab-Paclitaxel, and FOLFIRINOX for Patients with Inoperable Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Norway
  • Study comparing stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab in patients with aggressive relapsing-remitting multiple sclerosis

    Not recruiting

    3 1 1 1
    Denmark The Netherlands Norway Sweden
  • Study of nirmatrelvir and ritonavir (Paxlovid) for prevention of long COVID-19 in patients with acute COVID-19 infection in Norway

    Not recruiting

    3 1 1
    Investigated drugs:
    Norway